Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation
- PMID: 18797894
- DOI: 10.1007/s00403-008-0890-x
Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation
Abstract
At least 71 patients have been reported in which their otherwise typical subacute cutaneous lupus erythematosus (SCLE) skin lesions were felt to have been temporally associated with the systemic administration of a drug. The mean age of this cohort of drug-induced SCLE (DI-SCLE) patients was 59 years of age which is somewhat older than the mean age of previously reported idiopathic SCLE patient cohorts. Patients had been taking the suspected triggering drug for weeks to years before the onset of SCLE skin lesions. In addition, it was not unusual for 2-3 months to be required for resolution of the SCLE skin lesions following discontinuation of the triggering drug. A relatively large number of drugs representing different pharmacological classes have been implicated in the induction of SCLE. The drug classes that were more frequently encountered were those used for the treatment of cardiovascular disease, especially hypertension. Calcium channel blockers were especially common in this regard. Elderly individuals being treated for hypertension are often taking multiple classes of drugs that have been implicated in triggering SCLE (thiazide diuretics, calcium channel blockers, angiotensin converting enzyme (ACE) inhibitors, beta-blockers). An approach to the management of DI-SCLE is presented. Ro/SS-A autoantibodies tended to remain present in the blood after resolution of drug-induced SCLE skin lesions. A common link between the disparate group of drug structures implicated in triggering SCLE is their tendencies to produce photosensitivity and lichenoid drug reactions. This leads to the speculation that DI-SCLE could represent a photo-induced isomorphic/Köebner response in an immunogenetically predisposed host.
Similar articles
-
Drug-induced lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):99-105. doi: 10.1007/s00403-008-0895-5. Epub 2008 Sep 17. Arch Dermatol Res. 2009. PMID: 18797892 Review.
-
Drug-induced cutaneous lupus erythematosus: 88 new cases.Eur J Dermatol. 2017 Feb 1;27(1):28-33. doi: 10.1684/ejd.2016.2912. Eur J Dermatol. 2017. PMID: 27799135
-
Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.Lupus. 1997;6(1):32-9. doi: 10.1177/096120339700600105. Lupus. 1997. PMID: 9116716
-
A systematic review of drug-induced subacute cutaneous lupus erythematosus.Br J Dermatol. 2011 Mar;164(3):465-72. doi: 10.1111/j.1365-2133.2010.10110.x. Epub 2011 Feb 17. Br J Dermatol. 2011. PMID: 21039412 Review.
-
Drug-induced lupus: an update on its dermatologic aspects.Lupus. 2009 Oct;18(11):935-40. doi: 10.1177/0961203309106176. Lupus. 2009. PMID: 19762393 Review.
Cited by
-
Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases.Clin Cosmet Investig Dermatol. 2022 Oct 26;15:2285-2312. doi: 10.2147/CCID.S360801. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36320926 Free PMC article. Review.
-
Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature.Indian Dermatol Online J. 2022 Jan 24;13(1):64-72. doi: 10.4103/idoj.idoj_237_21. eCollection 2022 Jan-Feb. Indian Dermatol Online J. 2022. PMID: 35198470 Free PMC article.
-
Treatment patterns and control of hypertension in systemic lupus erythematosus (SLE): a cross-sectional study.BMJ Open. 2021 Nov 1;11(11):e048384. doi: 10.1136/bmjopen-2020-048384. BMJ Open. 2021. PMID: 34725073 Free PMC article.
-
Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.Curr Dermatol Rep. 2013 Mar;2(1):48-57. doi: 10.1007/s13671-012-0037-3. Epub 2013 Jan 24. Curr Dermatol Rep. 2013. PMID: 33585073 Free PMC article.
-
Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.Drugs R D. 2020 Dec;20(4):319-330. doi: 10.1007/s40268-020-00320-5. Drugs R D. 2020. PMID: 32960413 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous